Editors
- Andreas du Bois,Arbeitsgemeinschaft Gynaekologische Onkologie Study Group Kliniken Essen-Mitte, Department of Gynaecology and Gynaecologic Oncology, Essen, Germany
- Marcia Hall, Mount Vernon Cancer Centre Northwood, UK
- Christina C Fotopoulou, Ovarian Cancer Action Research Centre Department of Surgery and Cancer Imperial College London, UK
Series editor: Michele Ghielmini, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland
Contributors
Chapter 1 - Histopathology of gynaecological cancers
- GD Aletti - Department of Gynaecologic Oncology, European Institute of Oncology, Milan, Italy
- S Carinelli - Department of Pathology, European Institute of Oncology, Milan, Italy
Chapter 2 - Staging and surgical treatment of ovarian cancer
- S Mahner - Department of Gynecology and Obstetrics, University of Munich, Munich, Germany
- L Woelber - University Medical Center Hamburg-Eppendorf, Department of Gynecology, Hamburg, Germany
Chapter 3 - Systemic treatment of ovarian cancer
- D Krell - Mount Vernon Cancer Centre, Northwood, UK
- M Hall - Mount Vernon Cancer Centre, Northwood, UK
Chapter 4 - Staging and surgical treatment of endometrial cancer
- MJ Halaska - Gynecologic Oncology Center, Department of Obstetrics and Gynecology, University Hospital Kralovske Vinohrady, Third Medical Faculty, Charles University, Prague, Czech Republic
- L Rob - Gynecologic Oncology Center, Department of Obstetrics and Gynecology, University Hospital Kralovske Vinohrady, Third Medical Faculty, Charles University, Prague, Czech Republic
Chapter 5 - Non-surgical treatment of endometrial cancer
- M Mirza - Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
Chapter 6 - Staging and surgical treatment of cervical cancer
- D Cibula - Gynecologic Oncology Center, Department of Obstetrics and Gynecology, Charles University in Prague and General University Hospital in Prague, Czech Republic
Chapter 7 - Non-surgical treatment of cervical cancer
- S Marnitz - Department of Radiation Oncology, Charité University Medicine, Berlin, Germany
CC Fotopoulou - Department of Gynecological Oncology, Imperial College London, London, UK
Chapter 8 - Epidemiology and risk factors for ovarian, uterine and cervical cancers
- A Gonzalez Martin - MD Anderson Cancer Center, Madrid, Spain
Chapter 9 - Diagnosis and treatment of vulvar cancer
- L Rob - Gynecologic Oncology Center, Department of Obstetrics and Gynecology, University Hospital Kralovske Vinohrady, Third Medical Faculty, Charles University, Prague, Czech Republic
- P Skapa - Department of Pathology and Molecular Biology, Second Medical Faculty, Charles University, Prague, Czech Republic
Chapter 10 - Rare gynaecological cancers
- I Ray-Coquard - Medical Oncology, Centre Léon Bérard, Lyon, France
- H Vanacker - Medical Oncology, Centre Léon Bérard, Lyon, France
Chapter 11 - Hereditary ovarian and uterine cancer syndromes
- C Marth - Department of Obstetrics and Gynecology, Medical University, Innsbruck, Austria
Chapter 12 - New drugs and novel treatment strategies for gynaecological cancers
- M Zweifel - Department of Medical Oncology, University Hospital Bern, Switzerland
- C Sessa - Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland
Declarations of interest
- GD Aletti: No conflicts of interest.
- S Carinelli: No conflicts of interest.
- D Cibula: No conflicts of interest.
- CC Fotopoulou: No conflicts of interest.
- A Gonzalez Martin: No conflicts of interest.
- MJ Halaska: No conflicts of interest.
- M Hall: Advisory Boards for GlaxoSmithKline, Roche, AstraZeneca, Merck.
- D Krell: No conflicts of interest.
- S Mahner: No conflicts of interest.
- S Marnitz: No conflicts of interest.
- C Marth: No conflicts of interest.
- M Mirza: No conflicts of interest.
- I Ray-Coquard: No conflicts of interest.
- L Rob: No conflicts of interest.
- C Sessa: No conflicts of interest.
- P Skapa: No conflicts of interest.
- H Vanacker: No conflicts of interest.
- L Woelber: No conflicts of interest.
- M Zweifel: Advisory role for Roche.